相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Atopic dermatitis displays stable and dynamic skin transcriptome signatures
Lena Mobus et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)
Treatment-emergent adverse events in dupilumab-treated patients with allergic diseases: A meta-analysis
Xiaohong Chen et al.
ALLERGY (2021)
Incidence and risk factors for dupilumab associated ocular adverse events: a real-life prospective study
A. T. Touhouche et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2021)
Dupilumab-Associated Ocular Surface Disease: Clinical Characteristics, Treatment, and Follow-Up
Austin Bohner et al.
CORNEA (2021)
Real-world evidence of dupilumab efficacy and risk of adverse events: A systematic review and meta-analysis
Anne-Sofie Halling et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2021)
Effectiveness of dupilumab treatment in 95 patients with atopic dermatitis: daily practice data
L. E. M. de Wijs et al.
BRITISH JOURNAL OF DERMATOLOGY (2020)
Phase 2B randomized study of nemolizumab in adults with moderate-to-severe atopic dermatitis and severe pruritus
Jonathan Silverberg et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis A Phase 3 Randomized Clinical Trial
Eric L. Simpson et al.
JAMA DERMATOLOGY (2020)
Baricitinib in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phaseIIItrials
E. L. Simpson et al.
BRITISH JOURNAL OF DERMATOLOGY (2020)
Efficacy of Dupilumab in a Phase 2 Randomized Trial of Adults With Active Eosinophilic Esophagitis
Ikuo Hirano et al.
GASTROENTEROLOGY (2020)
Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines-Recommendations on the use of biologicals in severe asthma
Ioana Agache et al.
ALLERGY (2020)
New and Emerging Systemic Treatments for Atopic Dermatitis
Megan Newsom et al.
DRUGS (2020)
Cutaneous barrier dysfunction in allergic diseases
Donald Y. M. Leung et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Trial of Nemolizumab and Topical Agents for Atopic Dermatitis with Pruritus
Kenji Kabashima et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Treatment of atopic dermatitis with tralokinumab, an anti-IL-13 mAb
Andreas Wollenberg et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis
Emma Guttman-Yassky et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
GBR 830, an anti-OX40, improves skin gene signatures and clinical scores in patients with atopic dermatitis
Emma Guttman-Yassky et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in a real-life French multicenter adult cohort
Sarah Faiz et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2019)
Conjunctivitis in dupilumab clinical trials
B. Akinlade et al.
BRITISH JOURNAL OF DERMATOLOGY (2019)
Goblet cell scarcity and conjunctival inflammation during treatment with dupilumab in patients with atopic dermatitis
D. S. Bakker et al.
BRITISH JOURNAL OF DERMATOLOGY (2019)
Effect of dupilumab on atopic manifestations in patients treated for atopic dermatitis in real-life practice
M. Tauber et al.
BRITISH JOURNAL OF DERMATOLOGY (2019)
Dupilumab-Induced Follicular Conjunctivitis
Elizabeth Shen et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2019)
Strategies for Successful Management of Severe Atopic Dermatitis
Kanwaljit K. Brar et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2019)
Ocular Surface Diseases Induced by Dupilumab in Severe Atopic Dermatitis
Adrien Maudinet et al.
OPHTHALMOLOGY AND THERAPY (2019)
Atopic dermatitis yardstick: Practical recommendations for an evolving therapeutic landscape
Mark Boguniewicz et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2018)
Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical trial (LIBERTY AD CAFE)
M. de Bruin-Weller et al.
BRITISH JOURNAL OF DERMATOLOGY (2018)
Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: A randomized, placebo-controlled phase II trial (TREBLE)
Eric L. Simpson et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)
Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I
A. Wollenberg et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2018)
Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma
Klaus F. Rabe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma
M. Castro et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Significance of Skin Barrier Dysfunction in Atopic Dermatitis
Byung Eui Kim et al.
ALLERGY ASTHMA & IMMUNOLOGY RESEARCH (2018)
Conjunctivitis occurring in atopic dermatitis patients treated with dupilumab-clinical characteristics and treatment
Andreas Wollenberg et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2018)
Atopic dermatitis
Stephan Weidinger et al.
NATURE REVIEWS DISEASE PRIMERS (2018)
The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies
Patrick M. Brunner et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial
Andrew Blauvelt et al.
LANCET (2017)
Staphylococcus aureus and Staphylococcus epidermidis strain diversity underlying pediatric atopic dermatitis
Allyson L. Byrd et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Petrolatum: Barrier repair and antimicrobial responses underlying this inert moisturizer
Tali Czarnowicki et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial
Sally Wenzel et al.
LANCET (2016)
Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial
Diamant Thaci et al.
LANCET (2016)
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
E. L. Simpson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
The translational revolution and use of biologics in patients with inflammatory skin diseases
Shinji Noda et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
IL-13 Stimulates Proliferation and Expression of Mucin and Immunomodulatory Genes in Cultured Conjunctival Goblet Cells
Johanna Tukler Henriksson et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2015)
Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis
Jennifer D. Hamilton et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
Atopic keratoconjunctivitis: A review
Joseph J. Chen et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2014)
Atopic dermatitis: a disease of altered skin barrier and immune dysregulation
Mark Boguniewicz et al.
IMMUNOLOGICAL REVIEWS (2011)
Atopic keratoconjunctivitis and atopic dermatitis
Stefano Guglielmetti et al.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Atopic Dermatitis and Keratoconjunctivitis
Brett Bielory et al.
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2010)
Defective killing of Staphylococcus aureus in atopic dermatitis is associated with reduced mobilization of human β-defensin-3
Kevin O. Kisich et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
Immunopathogenesis of ocular allergy: a schematic approach to different clinical entities
Andrea Leonardi et al.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Cytokine modulation of atopic dermatitis filaggrin skin expression
Michael D. Howell et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
分享论文
